Literature DB >> 923556

A correlation of the endoscopic and pathological changes in subclinical pathology of the horse's larynx.

I D Duncan, G J Baker, C J Heffron, I R Griffiths.   

Abstract

The larynges of 6 horses were examined endoscopically and the findings correlated with the gross and histological appearance of the intrinsic laryngeal muscles and their nerve supply. In all cases it appeared that the balance between abductor and adductor muscle groups had been lost due to preferential atrophy of individual muscles or groups of muscles. The laryngeal abnormalities recorded were asymmetry of the larynx with asynchronous left sided abduction and fluttering or trembling of the left vocal cord and arytenoid cartilage. It is suggested that these changes represent the early signs of a progressive lesion which may result in left sided laryngeal hemiplegia.

Entities:  

Mesh:

Year:  1977        PMID: 923556     DOI: 10.1111/j.2042-3306.1977.tb04036.x

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  4 in total

1.  Determination of the early age of onset of equine recurrent laryngeal neuropathy. 1. Muscle pathology.

Authors:  G D Harrison; I D Duncan; M K Clayton
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Immunohistochemical analysis of laryngeal muscles in normal horses and horses with subclinical recurrent laryngeal neuropathy.

Authors:  Hannah S Rhee; Catherine M Steel; Frederik J Derksen; N Edward Robinson; Joseph F Y Hoh
Journal:  J Histochem Cytochem       Date:  2009-04-27       Impact factor: 2.479

3.  Correlation of the Havemeyer endoscopic laryngeal grading system with histopathological changes in equine Cricoarytenoideus dorsalis muscles.

Authors:  N Collins; E Milne; C Hahn; P Dixon
Journal:  Ir Vet J       Date:  2009-05-01       Impact factor: 2.146

Review 4.  Pathological classification of equine recurrent laryngeal neuropathy.

Authors:  Alexandra C E Draper; Richard J Piercy
Journal:  J Vet Intern Med       Date:  2018-04-24       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.